Mount Pleasant Orellana Aff
| Tournament | Round | Opponent | Judge | Cites | Round Report | Open Source | Edit/Delete |
|---|---|---|---|---|---|---|---|
| all saints | 2 | newman smith VY | adriar sendejas |
|
| ||
| contact information | Finals | na | na |
|
|
|
| Tournament | Round | Report |
|---|---|---|
| contact information | Finals | Opponent: na | Judge: na contact information found on cites |
To modify or delete round reports, edit the associated round.
Cites
| Entry | Date |
|---|---|
00 - contact informationTournament: contact information | Round: Finals | Opponent: na | Judge: na beforehand, i just wanted to clarify that LD isn't my "central" debate event ! with that being said, feel free to email me at: aoorellana535@gmail.com additionally, please let me know ... | 10/15/21 |
1AC - intellectual property rightsTournament: all saints | Round: 2 | Opponent: newman smith VY | Judge: adriar sendejas 1ACintellectual property rights1AC – frameworkextinction categorically outweighs because of future generations, life is a prerequisite—you have a cognitive bias against existential impacts but they're likely absent structures that prevent them, we also prioritize individual livesGPP 17 (Global Priorities Project, Future of Humanity Institute at the University of Oxford, Ministry for Foreign Affairs of Finland, "Existential Risk: Diplomacy and Governance," Global Priorities Project, 2017, https://www.fhi.ox.ac.uk/wp-content/uploads/Existential-Risks-2017-01-23.pdf , thanks Eyan~ thus, i affirm – resolved: the member nations of the world trade organization ought to reduce intellectual property rights for medicines1AC – advantagethe advantage is innovation.medical innovation in crisis – rarely do new drugs improve health outcomes due to new patents being only marginally better than older drugNaci et al. 15 ~Huseyin Naci, assistant professor of health policy at the LSE Health analysis center at the Department of Social Policy for the London School of Economics and Political Science , Alexander W Carter policy fellow, at the Institute of Global Health Innovation, Imperial College London, Elias Mossialos, professor of health policy, , at the LSE Health analysis center at the Department of Social Policy for the London School of Economics and Political Science, 10-23-2015, "Why the drug development pipeline is not delivering better medicines," BMJ, https://sci-hub.se/https://www.bmj.com/content/351/bmj.h5542.full~~ incremental changes increase average patent expiration dates, delaying generics and competition for decades – that harms innovationNawrat 19 ~Allie Nawrat, journalist with a BS in history and politics from the University of York, 11-12-2019, "From evergreening to thicketing: exploring the manipulation of pharma patents," Pharmaceutical Technology, https://www.pharmaceutical-technology.com/features/pharma-patents-manpulation/~~/Kankee anti-competitive practices allow monopolies to charge artificially outrageous costs that hurts consumersRajkumar 20 ~S. Vincent Rajkumar, Professor of Medicine at the Mayo Clinic, 2020, "The high cost of prescription drugs: causes and solutions," Blood and Cancer, https://www.nature.com/articles/s41408-020-0338-x~~/Kankee 1 – accessibility – IPR's severely impedes access to drugs which ensures inaccessibility – that increases the risk of disease and pandemicsSmith et al., 9 — PhD, Professor at the Health Policy Unit, Department of Public Health and Policy, London School of Hygiene and Tropical Medicine that causes extinctionOrd, Senior Research Fellow at Oxford, '20 ~Toby; reporter for the Guardian; 3-6-2020; "Why we need worst-case thinking to prevent pandemics"; Guardian; https://www.theguardian.com/science/2020/mar/06/worst-case-thinking-prevent-pandemics-coronavirus-existential-risk~~ 2 – climate change – pharma spills-over – has cascading global impacts that are necessary for human survivalNAS 8 (National Academy of Sciences 12-3-2008 "The Role of the Life Sciences in Transforming America's Future Summary of a Workshop") climate change causes extinctionSprat and Dunlop 19 (David Spratt and Ian Dunlop, *Research Director for Breakthrough National Centre for Climate Restoration and co-author of Climate Code Red: The case for emergency action; member of the Club of Rome AND formerly an international oil, gas and coal industry executive, chairman of the Australian Coal Association, chief executive of the Australian Institute of Company Directors, and chair of the Australian Greenhouse Office Experts Group on Emissions Trading, "Existential climate-related security risk: A scenario approach," Breakthrough National Centre for Climate Restoration, https://docs.wixstatic.com/ugd/148cb0_90dc2a2637f348edae45943a88da04d4.pdf)//BB 3 – health diplomacy – expanding breadth of Pharma innovation into neglected diseases results in global linkages that revitalizes global health diplomacy.Hotez 16, Peter J. Blue marble health: an innovative plan to fight diseases of the poor amid wealth. JHU Press, 2016. (Sabin Vaccine Institute and Texas Children's Hospital Center for Vaccine Development, Departments of Pediatrics and Molecular Virology and Microbiology)Elmer that solves hotspot escalationNang and Martin 17, Roberto N., and Keith Martin. "Global health diplomacy: A new strategic defense pillar." Military medicine 182.1-2 (2017): 1456-1460. (MC, Global Health Division, Uniformed Services University of the Health Sciences)Elmer | 10/15/21 |
Open Source
| Filename | Date | Uploaded By | Delete |
|---|